Nasal Polyps Clinical Research Studies

Interested in joining a clinical research trial?

We are currently conducting nasal polyps studies involving the use of biologics (complicated molecules that are manufactured within a living organism) for the treatment of bilateral (both nostrils) polyps. We are partnered with a local ENT physician who provides in-depth knowledge and expertise of nasal issues. These medications are provided at absolutely no cost, with no insurance needed. You may also be reimbursed for your time and travel and will receive care from physicians affiliated with the Clinical Research Center of Alabama.

For more information on any of the following nasal polyps clinical research studies, please contact Will O’Donnell by calling 205.209.4179 or emailing wodonnell@alabamaallergy.com

Injection

Age 19+

Genentech Nasal Polyps

The purpose of the study is to compare the effects, good and/or bad, of omalizumab (Xolair®) versus placebo (an inactive substance) on you and your nasal polyps. Both patients receiving omalizumab and those receiving placebo will be treated with an intranasal corticosteroid spray called mometason furoate.

Become a Participant in our Nasal Polyps Studies

If you’re interested in participating in a clinical research study at the Clinical Research Center of Alabama, call 205.209.4100 to speak with an experienced coordinator or fill out the contact form below.